| pubmed-article:21415776 | rdf:type | pubmed:Citation | lld:pubmed |
| pubmed-article:21415776 | lifeskim:mentions | umls-concept:C0030705 | lld:lifeskim |
| pubmed-article:21415776 | lifeskim:mentions | umls-concept:C1522449 | lld:lifeskim |
| pubmed-article:21415776 | lifeskim:mentions | umls-concept:C0817096 | lld:lifeskim |
| pubmed-article:21415776 | lifeskim:mentions | umls-concept:C0007131 | lld:lifeskim |
| pubmed-article:21415776 | lifeskim:mentions | umls-concept:C0008838 | lld:lifeskim |
| pubmed-article:21415776 | lifeskim:mentions | umls-concept:C0441771 | lld:lifeskim |
| pubmed-article:21415776 | lifeskim:mentions | umls-concept:C0246415 | lld:lifeskim |
| pubmed-article:21415776 | lifeskim:mentions | umls-concept:C0210657 | lld:lifeskim |
| pubmed-article:21415776 | lifeskim:mentions | umls-concept:C0282460 | lld:lifeskim |
| pubmed-article:21415776 | lifeskim:mentions | umls-concept:C0332283 | lld:lifeskim |
| pubmed-article:21415776 | pubmed:issue | 5 | lld:pubmed |
| pubmed-article:21415776 | pubmed:dateCreated | 2011-5-30 | lld:pubmed |
| pubmed-article:21415776 | pubmed:databankReference | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21415776 | pubmed:abstractText | Pemetrexed has emerged as one of the most active agents for the treatment of patients with advanced non-small cell lung cancer (NSCLC). We conducted a phase II study to assess the efficacy and feasibility of integrating pemetrexed in a concurrent therapy plan for patients with stage III NSCLC. | lld:pubmed |
| pubmed-article:21415776 | pubmed:language | eng | lld:pubmed |
| pubmed-article:21415776 | pubmed:journal | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21415776 | pubmed:citationSubset | IM | lld:pubmed |
| pubmed-article:21415776 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21415776 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21415776 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21415776 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21415776 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21415776 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21415776 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21415776 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21415776 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21415776 | pubmed:chemical | http://linkedlifedata.com/r... | lld:pubmed |
| pubmed-article:21415776 | pubmed:status | MEDLINE | lld:pubmed |
| pubmed-article:21415776 | pubmed:month | May | lld:pubmed |
| pubmed-article:21415776 | pubmed:issn | 1556-1380 | lld:pubmed |
| pubmed-article:21415776 | pubmed:author | pubmed-author:ChenWeiW | lld:pubmed |
| pubmed-article:21415776 | pubmed:author | pubmed-author:RuckdeschelJo... | lld:pubmed |
| pubmed-article:21415776 | pubmed:author | pubmed-author:BurgerAngelik... | lld:pubmed |
| pubmed-article:21415776 | pubmed:author | pubmed-author:WozniakAntoin... | lld:pubmed |
| pubmed-article:21415776 | pubmed:author | pubmed-author:TurrisiAndrew... | lld:pubmed |
| pubmed-article:21415776 | pubmed:author | pubmed-author:GadgeelShiris... | lld:pubmed |
| pubmed-article:21415776 | pubmed:author | pubmed-author:KonskiAndreA | lld:pubmed |
| pubmed-article:21415776 | pubmed:author | pubmed-author:ValdiviesoMan... | lld:pubmed |
| pubmed-article:21415776 | pubmed:author | pubmed-author:PatelBhaumik... | lld:pubmed |
| pubmed-article:21415776 | pubmed:author | pubmed-author:BelzerKimberl... | lld:pubmed |
| pubmed-article:21415776 | pubmed:author | pubmed-author:HackstockDebo... | lld:pubmed |
| pubmed-article:21415776 | pubmed:author | pubmed-author:MarquetteLaur... | lld:pubmed |
| pubmed-article:21415776 | pubmed:issnType | Electronic | lld:pubmed |
| pubmed-article:21415776 | pubmed:volume | 6 | lld:pubmed |
| pubmed-article:21415776 | pubmed:owner | NLM | lld:pubmed |
| pubmed-article:21415776 | pubmed:authorsComplete | Y | lld:pubmed |
| pubmed-article:21415776 | pubmed:pagination | 927-33 | lld:pubmed |
| pubmed-article:21415776 | pubmed:meshHeading | pubmed-meshheading:21415776... | lld:pubmed |
| pubmed-article:21415776 | pubmed:meshHeading | pubmed-meshheading:21415776... | lld:pubmed |
| pubmed-article:21415776 | pubmed:meshHeading | pubmed-meshheading:21415776... | lld:pubmed |
| pubmed-article:21415776 | pubmed:meshHeading | pubmed-meshheading:21415776... | lld:pubmed |
| pubmed-article:21415776 | pubmed:meshHeading | pubmed-meshheading:21415776... | lld:pubmed |
| pubmed-article:21415776 | pubmed:meshHeading | pubmed-meshheading:21415776... | lld:pubmed |
| pubmed-article:21415776 | pubmed:meshHeading | pubmed-meshheading:21415776... | lld:pubmed |
| pubmed-article:21415776 | pubmed:meshHeading | pubmed-meshheading:21415776... | lld:pubmed |
| pubmed-article:21415776 | pubmed:meshHeading | pubmed-meshheading:21415776... | lld:pubmed |
| pubmed-article:21415776 | pubmed:meshHeading | pubmed-meshheading:21415776... | lld:pubmed |
| pubmed-article:21415776 | pubmed:meshHeading | pubmed-meshheading:21415776... | lld:pubmed |
| pubmed-article:21415776 | pubmed:meshHeading | pubmed-meshheading:21415776... | lld:pubmed |
| pubmed-article:21415776 | pubmed:meshHeading | pubmed-meshheading:21415776... | lld:pubmed |
| pubmed-article:21415776 | pubmed:meshHeading | pubmed-meshheading:21415776... | lld:pubmed |
| pubmed-article:21415776 | pubmed:meshHeading | pubmed-meshheading:21415776... | lld:pubmed |
| pubmed-article:21415776 | pubmed:meshHeading | pubmed-meshheading:21415776... | lld:pubmed |
| pubmed-article:21415776 | pubmed:meshHeading | pubmed-meshheading:21415776... | lld:pubmed |
| pubmed-article:21415776 | pubmed:meshHeading | pubmed-meshheading:21415776... | lld:pubmed |
| pubmed-article:21415776 | pubmed:meshHeading | pubmed-meshheading:21415776... | lld:pubmed |
| pubmed-article:21415776 | pubmed:meshHeading | pubmed-meshheading:21415776... | lld:pubmed |
| pubmed-article:21415776 | pubmed:meshHeading | pubmed-meshheading:21415776... | lld:pubmed |
| pubmed-article:21415776 | pubmed:meshHeading | pubmed-meshheading:21415776... | lld:pubmed |
| pubmed-article:21415776 | pubmed:meshHeading | pubmed-meshheading:21415776... | lld:pubmed |
| pubmed-article:21415776 | pubmed:meshHeading | pubmed-meshheading:21415776... | lld:pubmed |
| pubmed-article:21415776 | pubmed:meshHeading | pubmed-meshheading:21415776... | lld:pubmed |
| pubmed-article:21415776 | pubmed:meshHeading | pubmed-meshheading:21415776... | lld:pubmed |
| pubmed-article:21415776 | pubmed:meshHeading | pubmed-meshheading:21415776... | lld:pubmed |
| pubmed-article:21415776 | pubmed:year | 2011 | lld:pubmed |
| pubmed-article:21415776 | pubmed:articleTitle | Phase II study of pemetrexed and cisplatin, with chest radiotherapy followed by docetaxel in patients with stage III non-small cell lung cancer. | lld:pubmed |
| pubmed-article:21415776 | pubmed:affiliation | Thoracic Oncology Program, Karmanos Cancer Institute/Wayne State University, Detroit, Michigan, USA. gadgeels@karmanos.org | lld:pubmed |
| pubmed-article:21415776 | pubmed:publicationType | Journal Article | lld:pubmed |
| pubmed-article:21415776 | pubmed:publicationType | Research Support, Non-U.S. Gov't | lld:pubmed |
| pubmed-article:21415776 | pubmed:publicationType | Clinical Trial, Phase II | lld:pubmed |
